BIOMEDICAL DATA SOLUTIONS LIMITED
Get an alert when BIOMEDICAL DATA SOLUTIONS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£3.5m
+149.6% highest in 3 filed years
Net assets
£6.2m
+48.6% highest in 3 filed years
Employees
79
+5.3% highest in 3 filed years
Profit before tax
£2.6m
+7,703.8% highest in 3 filed years
Net assets
3-year trend · vs Technology median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £7,754,623 | £6,720,991 | £9,318,354 | +38.6% | |
| Operating profit | £717,180 | £40,089 | £2,606,964 | +6,402.9% | |
| Profit before tax | £714,644 | £33,463 | £2,611,376 | +7,703.8% | |
| Net profit | £543,465 | -£60,139 | £2,020,664 | +3,460% | |
| Cash | £1,311,918 | £1,385,380 | £3,457,697 | +149.6% | |
| Total assets less current liabilities | £4,411,989 | £4,345,266 | — | — | |
| Net assets | £4,220,862 | £4,160,723 | £6,181,387 | +48.6% | |
| Equity | £4,220,862 | £4,160,723 | £6,181,387 | +48.6% | |
| Average employees | 72 | 75 | 79 | +5.3% | |
| Wages | £3,982,445 | £4,315,474 | £4,797,606 | +11.2% | |
| Directors' remuneration | £145,905 | £126,515 | £397,551 | +214.2% | |
| Directors' pension contributions | £24,577 | £12,636 | £18,916 | +49.7% | |
| Highest paid director | £145,905 | £126,515 | £279,351 | +120.8% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Operating margin | 9.2% | 0.6% | 28.0% | |
| Net margin | 7.0% | -0.9% | 21.7% | |
| Return on capital employed | 16.3% | 0.9% | — | |
| Gearing (liabilities / total assets) | 26.4% | — | — | |
| Current ratio | 3.23x | 4.09x | 3.51x | |
| Interest cover | — | 4.49x | — |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 2 times since incorporation
- BIOMEDICAL DATA SOLUTIONS LIMITED 2020-05-05 → present
- STRATEC BIOMEDICAL UK LIMITED 2011-03-14 → 2020-05-05
- SANGUIN INTERNATIONAL LIMITED 1988-08-31 → 2011-03-14
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Forvis Mazars LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
Group structure
- BIOMEDICAL DATA SOLUTIONS LIMITED · parent
- Sanguin International Inc. 100%
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 17 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| JOHNSON, Ryan | Director | 2025-02-11 | May 1995 | British |
| STEAD, Rebecca | Director | 2019-04-01 | Oct 1979 | British |
Show 17 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| DEXTER, Mark | Secretary | 2012-02-13 | 2015-10-13 |
| DUCKWORTH, Anthony John | Secretary | — | 1999-08-31 |
| GREENWOOD-PHILLIPS, Benjamin | Secretary | 2025-02-11 | 2026-03-04 |
| WHELAN, Richard | Secretary | 1999-08-31 | 2012-02-13 |
| BAKKER, Pascal Denijs | Director | 2024-09-09 | 2025-02-11 |
| DEXTER, Mark | Director | 2011-11-01 | 2015-10-13 |
| DUCKWORTH, Anthony John | Director | — | 2001-02-01 |
| HIGGS, Connie | Director | 2015-11-01 | 2020-04-30 |
| HILL, Ian | Director | 2015-11-01 | 2018-10-31 |
| KUENZEL, Andreas | Director | 2014-07-01 | 2020-04-30 |
| PIEK, Jurriaan Leonard Jan Frederik | Director | 2020-05-04 | 2024-09-09 |
| PITTS, Elaine | Director | 1995-09-01 | 2014-07-31 |
| ROBERTS, Philip Richard | Director | 2011-03-15 | 2011-10-31 |
| SIEGLE, Robert, Dr | Director | 2011-03-15 | 2014-07-04 |
| VALE, David Roger | Director | — | 2007-10-31 |
| WHELAN, Richard | Director | — | 2012-05-25 |
| WOLFINGER, Markus Karl | Director | 2006-03-10 | 2011-03-15 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Stratec Biomedical Ag | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors, Significant influence | 2016-04-06 | Ceased 2020-05-04 |
Filing timeline
Last 20 of 145 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-09-15 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-09-14 | AA | accounts | Accounts with accounts type full | |
| 2026-03-12 | TM02 | officers | Termination secretary company with name termination date | |
| 2025-09-19 | AA | accounts | Accounts with accounts type full | |
| 2025-09-12 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-02-12 | AP03 | officers | Appoint person secretary company with name date | |
| 2025-02-12 | TM01 | officers | Termination director company with name termination date | |
| 2025-02-12 | AP01 | officers | Appoint person director company with name date | |
| 2024-10-08 | AA | accounts | Accounts with accounts type full | |
| 2024-09-22 | RP04CS01 | confirmation-statement | Second filing of confirmation statement with made up date | |
| 2024-09-22 | RP04CS01 | confirmation-statement | Second filing of confirmation statement with made up date | |
| 2024-09-22 | RP04CS01 | confirmation-statement | Second filing of confirmation statement with made up date | |
| 2024-09-18 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-09-09 | AP01 | officers | Appoint person director company with name date | |
| 2024-09-09 | TM01 | officers | Termination director company with name termination date | |
| 2024-04-03 | AA | accounts | Accounts with accounts type full | |
| 2023-11-08 | AD01 | address | Change registered office address company with date old address new address | |
| 2023-10-30 | AD01 | address | Change registered office address company with date old address new address | |
| 2023-09-05 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-10-05 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.